The Effects of External Beam Radiotherapy on the Normal Urinary Bladder-A Histopathological Review.

J Med Imaging Radiat Sci

Radiation Medicine Program, Princess Margaret Hospital and Department of Radiation Oncology, University of Toronto, Canada.

Published: December 2011

Introduction: This literature review presents information relevant to medical radiation technologists with respect to new knowledge on the function of the urinary bladder. These new insights are also explored in relation to radiation-induced histopathological effects and the symptoms of bladder dysfunction reported after external beam radiotherapy.

Methods And Materials: The peer-reviewed scientific literature was examined using various electronic medical search engines with appropriate keywords and MeSH headings. Inclusion criteria comprised English language articles published between 1999 and January 2010, with full manuscript available. A critical review was then performed, synthesizing the information contained in those multiple sources into the following subject categories: normal urinary bladder function (basic review and new knowledge), and effect of fractionated radiotherapy on normal bladder (histopathological changes and symptoms of dysfunction).

Findings: Previously considered an inert vessel for urine storage, the urinary bladder is actually a complex system of morphologically different tissues, which play an interconnected role in its physiological functions. Injury or abnormal repair in any of the bladder cell layers results in a multifaceted display of interrelated manifestations of dysfunction. In this complex environment, not only can a single symptom of dysfunction have multiple histopathological causes, but the presence of one symptom may exacerbate the presentation of another. To date, this new knowledge has had little impact on radiotherapy clinical practice because subjective methods of collecting toxicity data prevent the identification of a link between radiotherapy dose and urinary dysfunction. The new understanding of the histopathological cause of radiation-induced symptoms, however, has led to the preclinical investigation of many promising methods to prevent or reduce radiotherapy toxicity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmir.2011.03.002DOI Listing

Publication Analysis

Top Keywords

urinary bladder
12
external beam
8
radiotherapy normal
8
normal urinary
8
bladder
6
radiotherapy
5
urinary
5
histopathological
5
effects external
4
beam radiotherapy
4

Similar Publications

Recruitment and retention in cancer trials are long-standing issues, exacerbated by the COVID-19 pandemic. The UK National Institute of Health Research and leading clinicians have emphasised the urgency to achieve and surpass prepandemic levels of participation. Data from a recent UK trial demonstrated the impact of COVID-19 and highlighted factors that limited recruitment.

View Article and Find Full Text PDF

Objective: To compare health-related quality of life (HRQOL) in patients undergoing radical cystectomy with ileal conduit (RC) or bladder preservation (BP) with (chemo)radiotherapy for bladder cancer.

Methods And Analysis: Patients with bladder cancer, stage cT1-T4, cN0-N1, M0 with a minimum follow-up of 6 months from curative treatment (RC or BP) and without disease were eligible for inclusion. Two HRQOL instruments were administered: Bladder Cancer Index (BCI) for bladder cancer-specific HRQOL and European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).

View Article and Find Full Text PDF

Pembrolizumab is a monoclonal antibody directed against the programmed cell death-1 (PD1) receptor, which binds to PD1 receptors on T lymphocytes and blocks their inactivation by tumor cells. Pembrolizumab is not free from side effects, a rare one of which is hypocorticism. Here we present a patient with pembrolizumab-induced hypocorticism manifested by a cerebrovascular event.

View Article and Find Full Text PDF

Methyltrimethoxysilane (MTMS).

Toxicol Ind Health

January 2025

Cincinnati, OH, USA.

Methyltrimethoxysilane (MTMS) has been used as a coupling agent in thermoplastics and thermosetting resins, a cross-linker in silicone sealants, a water repellent component, and in silicone hard-coats for plastics. Acute studies in experimental animals showed a low order of toxicity for MTMS via oral, dermal, and inhalation routes. MTMS was slightly irritating to both eyes and skin in rabbits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!